Literature DB >> 32682363

Covid-19 infection and the host genetic predisposition: does it exist?

A Vašků1.   

Abstract

Knowledge of genomic interindividual variability could help us to explain why different manifestation of clinical severity of Covid-19 infection as well as modified pharmacogenetic relations can be expected during this pandemic condition.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32682363      PMCID: PMC8648312          DOI: 10.33549/physiolres.934504

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  20 in total

Review 1.  Angiotensin-converting enzyme 2--a new cardiac regulator.

Authors:  Manfred Boehm; Elizabeth G Nabel
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

2.  Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy.

Authors:  Wolfgang Lieb; Jochen Graf; Anika Götz; Inke R König; Björn Mayer; Marcus Fischer; Jan Stritzke; Christian Hengstenberg; Stephan R Holmer; Angela Döring; Hannelore Löwel; Heribert Schunkert; Jeanette Erdmann
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

3.  Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study.

Authors:  Qi Zhao; Dongfeng Gu; Tanika N Kelly; James E Hixson; Dabeeru C Rao; Cashell E Jaquish; Jing Chen; Jianfeng Huang; Chung-Shiuan Chen; C Charles Gu; Paul K Whelton; Jiang He
Journal:  Am J Hypertens       Date:  2010-03-11       Impact factor: 2.689

4.  Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Authors:  Michael A Crackower; Renu Sarao; Gavin Y Oudit; Chana Yagil; Ivona Kozieradzki; Sam E Scanga; Antonio J Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James Scholey; Carlos M Ferrario; Armen S Manoukian; Mark C Chappell; Peter H Backx; Yoram Yagil; Josef M Penninger
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

Review 5.  Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.

Authors:  Keiji Kuba; Yumiko Imai; Takayo Ohto-Nakanishi; Josef M Penninger
Journal:  Pharmacol Ther       Date:  2010-07-03       Impact factor: 12.310

Review 6.  Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill.

Authors:  Laurent Bitker; Louise M Burrell
Journal:  Crit Care Clin       Date:  2019-01-28       Impact factor: 3.598

7.  ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome.

Authors:  Rossa W K Chiu; Nelson L S Tang; David S C Hui; Grace T Y Chung; Stephen S C Chim; K C Allen Chan; Ying-man Sung; Louis Y S Chan; Yu-kwan Tong; Wing-shan Lee; Paul K S Chan; Y M Dennis Lo
Journal:  Clin Chem       Date:  2004-09       Impact factor: 8.327

8.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.

Authors:  Keiji Kuba; Yumiko Imai; Shuan Rao; Hong Gao; Feng Guo; Bin Guan; Yi Huan; Peng Yang; Yanli Zhang; Wei Deng; Linlin Bao; Binlin Zhang; Guang Liu; Zhong Wang; Mark Chappell; Yanxin Liu; Dexian Zheng; Andreas Leibbrandt; Teiji Wada; Arthur S Slutsky; Depei Liu; Chuan Qin; Chengyu Jiang; Josef M Penninger
Journal:  Nat Med       Date:  2005-07-10       Impact factor: 53.440

Review 9.  COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

Authors:  A Aleksova; F Ferro; G Gagno; C Cappelletto; D Santon; M Rossi; G Ippolito; A Zumla; A P Beltrami; G Sinagra
Journal:  J Intern Med       Date:  2020-06-08       Impact factor: 13.068

10.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

Authors:  I Hamming; W Timens; M L C Bulthuis; A T Lely; G J Navis; H van Goor
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

View more
  7 in total

Review 1.  Is there impact of the SARS-CoV-2 pandemic on steroidogenesis and fertility?

Authors:  N Knížatová; M Massányi; S Roychoudhury; P Guha; H Greifová; K Tokárová; T Jambor; P Massányi; N Lukáč
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

Review 2.  Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression.

Authors:  J A Hubacek
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

3.  SARS-CoV-2 viral load assessment in lung transplantation.

Authors:  R Novysedlak; J Vachtenheim; I Stříž; O Viklický; R Lischke; Z Strizova
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

Review 4.  Alveolar type II cells and pulmonary surfactant in COVID-19 era.

Authors:  A Calkovska; M Kolomaznik; V Calkovsky
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

Review 5.  Androgens in SARS-CoV-2 coronavirus infections.

Authors:  L Stárka; M Dušková
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

Review 6.  Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19.

Authors:  M Barnova; A Bobcakova; V Urdova; R Kosturiak; L Kapustova; D Dobrota; M Jesenak
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

7.  CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects.

Authors:  J A Hubacek; L Dusek; O Majek; V Adamek; T Cervinkova; D Dlouha; J Pavel; V Adamkova
Journal:  Physiol Res       Date:  2021-03-17       Impact factor: 1.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.